Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant Application
Sydney Children’s Hospital – $195,327 USD / $265,645 AUD (Approx)
$195,327.00 USD
September 2021
Phase I/II Study of Oral DFMO and AMXT1501 for DIPG/DMG
Children's Cancer Institute – $50,000 USD / $68,000 AUD (Approx)
$50,000.00 USD
September 2021
Developing Novel Combination Therapies for Diffuse Intrinsic Pontine Glioma
University of Queensland Diamantina Institute – $100,000 USD / $136,000 AUD (Approx)
$100,000.00 USD
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Children's Cancer Institute - $99,251 USD / $140,212 AUD (Approx)
$99,251.00 USD
September 2020
Discovering New Epigenetic Players in DIPG Oncogenesis
Hunter Medical Research Institute - $145,640 USD / $199,527 AUD (Approx)
$145,640.00 USD
September 2020
Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas
Sydney Children's Hospital - $151,468 USD / $219,386 AUD (Approx)
$151,468.00 USD
December 2019
Developing New Epigenetic Combination Treatments Against DIPG.
University of Sydney - $100,000 USD / $146,520 AUD (Approx)
$100,000.00 USD
November 2019
Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.
Telethon Kids Institute - $49,512 USD / $69,822 AUD (Approx)
$49,512.00 USD
August 2019
Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.
Sydney Children’s Hospital - $175,089 USD / $242,388 AUD (Approx)
$175,089.00 USD
November 2018
Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma
Children's Cancer Institute - $185,706 USD / $252,300 AUD (Approx)
$185,706.00 USD
October 2017
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1
Children's Cancer Institute - $143,884 USD / $190,718 AUD (Approx)
$143,884.00 USD
September 2016
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism
Children's Cancer Institute - $145,341 USD / $176,778 AUD (Approx)
$145,341.00 USD
November 2015
Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.
Children's Cancer Institute - $81,683 USD / $103,615 AUD (Approx)
$81,683.00 USD
February 2015
Facilitates Chromatin Transcription Complex (FACT): A novel therapeutic target against Diffuse Intrinsic Pontine Glioma.
Monash Institute of Medical Research - $99,620 USD / $94,450 AUD (Approx)
$99,620.00 USD
November 2013
Targeted Therapy and Stem Cell Therapy for DIPG
Sydney Children's Hospital - $100,000 USD / $105,370 AUD (Approx)
$100,000.00 USD
January 2013
Research of treatments for Diffuse Intrinsic Pontine Glioma (DIPG)